A 0.4 mg dose of aflibercept in infancy to treat retinopathy of prematurity (ROP) shows sustained efficacy and safety at 3 years of age, according to research presented at EURETINA 2024. No ...
Please provide your email address to receive an email when new articles are posted on . Retinopathy of prematurity occurs primarily in low birth weight premature infants who are admitted to a neonatal ...
Myopia, or nearsightedness, affects about a quarter of the U.S. population. It can be managed or delayed, but there is no known cure. If you can see things clearly up close, but they get blurrier as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback